摘要 |
<p>A process for preparing granisetron (1) or a pharmaceutically acceptable salt thereof, which process comprises deprotecting a compound of Structure (2), wherein R is a nitrogen-protecting group which does not significantly reduce the nucleophilicity of a secondary amino group, and optionally forming a pharmaceutically acceptable salt.</p> |